Lemonade, Inc. (NYSE:LMND) Director Maria Angelidis-Smith Purchases 15,042 Shares

Lemonade, Inc. (NYSE:LMND) Director Maria Angelidis-Smith acquired 15,042 shares of Lemonade stock in a transaction that occurred on Wednesday, November 13th. The shares were purchased at an average cost of $33.23 per share, for a total transaction of $499,845.66. Following the purchase, the director now directly owns 33,554 shares in the company, valued at $1,114,999.42. The trade was a 0.00 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Maria Angelidis-Smith also recently made the following trade(s):

• On Friday, November 8th, Maria Angelidis-Smith bought 18,512 shares of Lemonade stock. The shares were bought at an average price of $27.42 per share, for a total transaction of $507,599.04.

Lemonade Price Performance

Shares of Lemonade stock traded down $0.28 on Wednesday, reaching $31.99. 1,622,767 shares of the company’s stock were exchanged, compared to its average volume of 1,657,907. Lemonade, Inc. has a 52 week low of $14.03 and a 52 week high of $34.95. The firm’s 50-day moving average is $19.54 and its two-hundred day moving average is $18.29.

Lemonade (NYSE:LMND) last issued its earnings results on Wednesday, October 30th. The company reported ($0.95) earnings per share for the quarter, topping analysts’ consensus estimates of ($1.02) by $0.07. Lemonade had a negative return on equity of 32.85% and a negative net margin of 43.51%. The company had revenue of $136.60 million for the quarter, compared to analyst estimates of $129.10 million. During the same period in the prior year, the firm earned ($0.88) earnings per share. Lemonade’s revenue for the quarter was up 19.3% on a year-over-year basis. On average, equities analysts predict that Lemonade, Inc. will post -3.05 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several equities analysts recently weighed in on LMND shares. Keefe, Bruyette & Woods cut shares of Lemonade from a “market perform” rating to an “underperform” rating and raised their target price for the company from $18.00 to $21.00 in a research note on Thursday, November 7th. Jefferies Financial Group reduced their target price on shares of Lemonade from $15.00 to $14.00 and set an “underperform” rating for the company in a research report on Wednesday, October 9th. Piper Sandler boosted their target price on Lemonade from $18.00 to $25.00 and gave the stock a “neutral” rating in a research note on Friday, November 1st. Finally, JMP Securities reaffirmed a “market outperform” rating and issued a $40.00 price objective on shares of Lemonade in a research note on Tuesday, October 15th. Three equities research analysts have rated the stock with a sell rating, three have given a hold rating and one has issued a buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $21.83.

Institutional Investors Weigh In On Lemonade

Institutional investors and hedge funds have recently bought and sold shares of the stock. Susquehanna Fundamental Investments LLC bought a new stake in Lemonade during the 1st quarter valued at $477,000. Headlands Technologies LLC bought a new position in Lemonade in the 1st quarter worth about $231,000. State Board of Administration of Florida Retirement System grew its holdings in Lemonade by 18.7% during the 1st quarter. State Board of Administration of Florida Retirement System now owns 17,226 shares of the company’s stock valued at $283,000 after buying an additional 2,710 shares in the last quarter. HAP Trading LLC lifted its holdings in shares of Lemonade by 106.1% in the first quarter. HAP Trading LLC now owns 24,315 shares of the company’s stock worth $399,000 after buying an additional 12,515 shares in the last quarter. Finally, Price T Rowe Associates Inc. MD boosted its position in shares of Lemonade by 9.8% in the first quarter. Price T Rowe Associates Inc. MD now owns 24,609 shares of the company’s stock valued at $404,000 after acquiring an additional 2,196 shares during the period. 80.30% of the stock is owned by hedge funds and other institutional investors.

About Lemonade

Lemonade, Inc provides various insurance products through various channels in the United States, Europe, and the United Kingdom. Its insurance products include stolen or damaged property, and personal liability that protects its customers if they are responsible for an accident or damage to another person or their property.